LINC 2022: IN.PACT Global Study 5-Y Diabetic & Gender Subgroup Outcomes | Dr Marianne Brodmann

Просмотров: 61   |   Загружено: 2 год.
icon
Radcliffe Cardiology
icon
1
icon
Скачать
iconПодробнее о видео
Watch on Radcliffe Vascular:

Dr Marianne Brodmann (Medical University of Graz, AT) joins us at LINC 2022 to discuss the 5-year outcomes stratified according to gender and diabetes status in the IN.PACT Global Study.
TheIN.PACT Global Study assessed the safety and efficacy data on the IN.PACT Admiral™ Drug Eluting Balloon (DEB) (Medtronic) in treatment of atherosclerotic disease .

Discussion Points:
1. Study Background
2. IN.PACT™ AV Access Drug Coated Balloon
3. Key Results in Patients With Diabetes
4. Take-Home Messages

Recorded on-site at LINC, Leipzig, 2022.
This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Похожие видео

Добавлено: 55 год.
Добавил:
  © 2019-2021
  LINC 2022: IN.PACT Global Study 5-Y Diabetic & Gender Subgroup Outcomes | Dr Marianne Brodmann - RusLar.Me